Responses of volunteers to inactivated influenza virus vaccines
- PMID: 7007488
- PMCID: PMC2134056
- DOI: 10.1017/s0022172400068698
Responses of volunteers to inactivated influenza virus vaccines
Abstract
Three different types of bivalent influenza virus vaccine, a whole virus, an aqueous-surface-antigen vaccine and an adsorbed-surface-antigen vaccine were tested at three dosage levels in volunteers primed with respect to only one of the haemagglutinin antigens present in the vaccines. The local and systemic reactions to all three vaccine types were mild in nature and, following first immunization, the aqueous-surface-antigen vaccine was the least reactogenic. The serum haemagglutination-inhibiting antibody response to the A/Victoria/75 component of the vaccines to which the volunteer population was primed, was greatest following immunization with the aqueous-surface-antigen vaccine; the greatest antibody response to the A/New Jersey/76 component of the vaccines was observed following immunization with whole virus vaccine.
Similar articles
-
Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine.J Hyg (Lond). 1985 Feb;94(1):87-95. doi: 10.1017/s0022172400061167. J Hyg (Lond). 1985. PMID: 3973383 Free PMC article. Clinical Trial.
-
A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.J Hyg (Lond). 1984 Jun;92(3):263-76. doi: 10.1017/s0022172400064500. J Hyg (Lond). 1984. PMID: 6736638 Free PMC article.
-
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.J Hyg (Lond). 1983 Jun;90(3):351-9. doi: 10.1017/s0022172400028989. J Hyg (Lond). 1983. PMID: 6863909 Free PMC article.
-
Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers.J Infect Dis. 1978 Nov;138(5):577-86. doi: 10.1093/infdis/138.5.577. J Infect Dis. 1978. PMID: 712115
-
Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?Jpn J Infect Dis. 2016;69(3):165-79. doi: 10.7883/yoken.JJID.2015.560. Jpn J Infect Dis. 2016. PMID: 27212584 Review.
Cited by
-
Avian influenza virus (H5N1): a threat to human health.Clin Microbiol Rev. 2007 Apr;20(2):243-67. doi: 10.1128/CMR.00037-06. Clin Microbiol Rev. 2007. PMID: 17428885 Free PMC article. Review.
-
A comparison of adverse effects of two influenza vaccines, and the influence on subsequent uptake.J R Coll Gen Pract. 1984 Aug;34(265):442-4. J R Coll Gen Pract. 1984. PMID: 6471030 Free PMC article. Clinical Trial.
-
Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine.J Hyg (Lond). 1985 Feb;94(1):87-95. doi: 10.1017/s0022172400061167. J Hyg (Lond). 1985. PMID: 3973383 Free PMC article. Clinical Trial.
-
Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies.Eur J Clin Microbiol Infect Dis. 1996 Jan;15(1):65-70. doi: 10.1007/BF01586187. Eur J Clin Microbiol Infect Dis. 1996. PMID: 8641306
-
Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).Epidemiol Infect. 1987 Oct;99(2):501-15. doi: 10.1017/s095026880006800x. Epidemiol Infect. 1987. PMID: 3315713 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources